Faeth Therapeutics, Inc.

NASDAQ:FTH

Biotechnology

Healthcare
$8.72 +5.01%

+$1.43 today

Market cap
$224.79M
Beta
-0.31
P/E (TTM)
-0.2
EPS (TTM)
-$34.65
52W Low $7.21High $37.90

Volume 0.33M

Average 0.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$20.45M

FY 2025 · Annual

Investing Cash Flow

$19.77M

FY 2025 · Annual

-11.9% YoY

Financing Cash Flow

-$645,000.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(36.79M)(48.59M)(34.1M)(30.16M)(21.09M)
Depreciation & Amortization685K1.35M1.35M1.32M139K
Deferred Income Tax19K0000
Stock-Based Compensation5.66M5.81M4.45M3.14M1.27M
Change in Working Capital117K1.01M(4.33M)(489K)(1.59M)
Accounts Receivables00000
Inventory00000
Accounts Payables(1.43M)2.02M(2.33M)(445K)233K
Other Working Capital1.54M(1.01M)(2M)(44K)(1.83M)
Other Non-Cash Items57K1.4M603K1.52M811K
Operating Cash Flow(30.26M)(39.03M)(32.02M)(24.67M)(20.45M)
Capital Expenditures(2.03M)(321K)(180K)(146K)(16K)
Acquisitions (Net)318K15K166K0250K
Purchases of Investments(183.67M)(46.87M)(21.15M)(44.6M)(25.16M)
Sales of Investments42.26M97.12M59.58M67.18M44.69M
Other Investing Activities00000
Investing Cash Flow(143.12M)49.95M38.41M22.44M19.77M
Debt Repayment(255K)(629K)(761K)(811K)(648K)
Common Stock Issued140.59M342K48K34K7K
Common Stock Repurchased00(10.38M)0(1K)
Dividends Paid00000
Other Financing Activities109K0(76K)(10K)(3K)
Financing Cash Flow163.94M(287K)(11.17M)(787K)(645K)
Effect of Forex Changes00000
Net Change in Cash(9.44M)10.64M(4.78M)(3.02M)(1.33M)
Free Cash Flow(32.29M)(39.35M)(32.2M)(24.82M)(20.47M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$21.1M
+ D&A$139.0K
+ Stock-Based Comp$1.3M
+ Deferred Tax$0
- Working Capital-$1.6M
+ Other Non-Cash$811.0K
= Operating Cash Flow-$20.5M
- Capex-$16.0K
= Free Cash Flow-$20.5M

Analysis

FY2025 free cash flow is -$20.5M. FCF conversion is 97.1% of net income. Operating cash flow was -$20.5M, with capex of -$16.0K. The largest bridge item is Working Capital at -$1.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 3, 2026
S-8S-8 filingNov 3, 2026

Does FTH generate free cash flow?

Faeth Therapeutics, Inc. (FTH) generated -$20.47M of free cash flow in fiscal 2025.

How much operating cash flow does FTH produce?

Operating cash flow was -$20.45M, before capital expenditures of $16,000.00.